Market Overview

Benzinga's Top Upgrades, Downgrades For November 10, 2017

Share:

Top Upgrades

  • Baird upgraded Kohl's Corporation (NYSE: KSS) from Neutral to Outperform. Kohl's shares fell 0.66 percent to $40.90 in pre-market trading.
  • RBC Capital upgraded Perrigo Company plc (NYSE: PRGO) from Underperform to Market Perform. Perrigo shares climbed 8.36 percent to close at $87.99 on Thursday.
  • Analysts at Jefferies upgraded Zoe's Kitchen Inc (NYSE: ZOES) from Hold to Buy. Zoe's Kitchen shares rose 2.36 percent to $11.27 in pre-market trading.
  • Macquarie upgraded Kinross Gold Corporation (USA) (NYSE: KGC) from Neutral to Outperform. Kinross Gold shares rose 4.55 percent to close at $4.37 on Thursday.
  • Roth Capital upgraded Canadian Solar Inc. (NASDAQ: CSIQ) from Neutral to Buy. Canadian Solar shares dropped 10.76 percent to close at $16.84 on Thursday.
  • Raymond James upgraded Aaron's, Inc. (NYSE: AAN) from Market Perform to Strong Buy. Aaron's shares declined 1.03 percent to close at $35.62 on Thursday.
  • Berenberg upgraded Hyatt Hotels Corporation (NYSE: H) from Hold to Buy. Hyatt shares fell 0.56 percent to $68.81 in pre-market trading.
  • Analysts at Nomura upgraded NVIDIA Corporation (NASDAQ: NVDA) from Reduce to Neutral. NVIDIA shares rose 4.93 percent to $215.44 in pre-market trading.
  • Needham upgraded CVS Health Corp (NYSE: CVS) from Hold to Buy. CVS shares rose 0.70 percent to $69.50 in pre-market trading.
  • Bank of America upgraded UBS Group AG (USA) (NYSE: UBS) from Neutral to Buy. UBS shares rose 1.18 percent to $17.13 in pre-market trading.


Top Downgrades

  • Cowen & Co. downgraded Finish Line Inc (NASDAQ: FINL) from Market Perform to Underperform. Finish Line shares gained 4.17 percent to close at $10.00 on Thursday.
  • Bank of America downgraded Frontier Communications Corp (NASDAQ: FTR) from Neutral to Underperform. Frontier Communications shares fell 6.91 percent to $7.41 in pre-market trading.
  • Analysts at Roth Capital downgraded Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) from Buy to Neutral. Titan Pharmaceuticals shares dropped 12.50 percent to close at $1.58 on Thursday.
  • Canaccord Genuity downgraded Sequential Brands Group Inc (NASDAQ: SQBG) from Buy to Hold. Sequential Brands shares fell 38.82 percent to close at $1.45 on Thursday.
  • SunTrust Robinson Humphrey downgraded Esterline Technologies Corporation (NYSE: ESL) from Buy to Hold. Esterline Technologies shares declined 4.04 percent to close at $89.39 on Thursday.
  • Baird downgraded Spirit Realty Capital, Inc (New) (NYSE: SRC) from Outperform to Neutral. Spirit Realty Capital shares closed at $8.62 on Thursday.
  • Sandler O'Neill downgraded Metlife Inc (NYSE: MET) from Buy to Hold. MetLife shares closed at $52.81 on Thursday.
  • Citigroup downgraded Marathon Oil Corporation (NYSE: MRO) from Buy to Neutral. Marathon Oil shares fell 0.51 percent to $15.70 in pre-market trading.
  • Barclays downgraded Edgewell Personal Care Co (NYSE: EPC) from Equal-Weight to Underweight. Edgewell Personal Care shares fell 1.31 percent to $58.60 in pre-market trading.
  • Analysts at Vertical Research Partners downgraded Johnson Controls International plc (NYSE: JCI) from Buy to Hold. Johnson Controls shares declined 6.07 percent to close at $38.51 on Thursday.


Top Initiations

  • Analysts at Wells Fargo initiated coverage on TE Connectivity Ltd (NYSE: TEL) with an Outperform rating. The price target for TE Connectivity is set to $105. TE Connectivity shares closed at $92.92 on Thursday.
  • H.C. Wainwright assumed coverage on Viking Therapeutics Inc (NASDAQ: VKTX) with a Buy rating. The price target for Viking Therapeutics set to $7. Viking Therapeutics shares closed at $2.19 on Thursday.
  • Analysts at Bank of America initiated coverage on Ablynx NV (NASDAQ: ABLX) with a Buy rating. The price target for Ablynx is set to $26. Ablynx shares closed at $20.75 on Thursday.
  • Wells Fargo initiated coverage on Amphenol Corporation (NYSE: APH) with an Outperform rating. The price target for Amphenol set to $98. Amphenol shares closed at $86.72 on Thursday.
  • Analysts at H.C. Wainwright assumed coverage on Jazz Pharmaceuticals plc (NASDAQ: JAZZ) with a Neutral rating. The price target for Jazz Pharmaceuticals is set to $150. Jazz Pharmaceuticals shares closed at $135.31 on Thursday.
 

Related Articles (AAN + ABLX)

View Comments and Join the Discussion!

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
DELLUBSUpgrades
HPQUBSUpgrades25.0
MOSCleveland ResearchUpgrades23.0
WDCCleveland ResearchUpgrades
MUCleveland ResearchUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com